Historical Stock Price
|
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACER Historical Stock Prices |
| Preferred Stock Newsletter |
| Top Option Ideas |
| Stock Message Boards |
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on August 12, 2019, ACER opened at $2.35, traded as high as $2.40 and as low as $2.20, and closed at $2.31. Trading volume was a total of 95.90K shares. On August 13, 2019, ACER opened at $2.30, traded as high as $2.50 and as low as $2.22, and closed at $2.45. Trading volume was a total of 69.70K shares. On August 14, 2019, ACER opened at $2.08, traded as high as $2.39 and as low as $2.08, and closed at $2.17. Trading volume was a total of 124.60K shares. On August 15, 2019, ACER opened at $2.15, traded as high as $2.15 and as low as $1.93, and closed at $1.95. Trading volume was a total of 130.30K shares. On August 16, 2019, ACER opened at $1.99, traded as high as $2.19 and as low as $1.87, and closed at $2.09. Trading volume was a total of 481.90K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 08/17/2009 | |
| End date: | 08/16/2019 | |
| Start price/share: | $14.58 | |
| End price/share: | $2.09 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -85.67% | |
| Average Annual Total Return: | -17.65% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $1,433.52 | |
| Years: | 10.00 | |
 | |||||
| ACER Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 08/12/2019 | $2.35 | $2.40 | $2.20 | $2.31 | 95.90K |
| 08/13/2019 | $2.30 | $2.50 | $2.22 | $2.45 | 69.70K |
| 08/14/2019 | $2.08 | $2.39 | $2.08 | $2.17 | 124.60K |
| 08/15/2019 | $2.15 | $2.15 | $1.93 | $1.95 | 130.30K |
| 08/16/2019 | $1.99 | $2.19 | $1.87 | $2.09 | 481.90K |
|
| About Acer Therapeutics |
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need. Co.'s late-stage clinical pipeline includes two candidates for severe genetic disorders: EDSIVO™ (celiprolol), which is a selective adrenergic modulator and a new chemical entity for the treatment of vascular Ehlers-Danlos syndrome; and ACER-001, which is a taste-masked, immediate release formulation of sodium phenylbutyrate, designed to treat urea cycle disorders and Maple Syrup Urine Disease. |
| ACER Historical Closing Prices | |
| Date | Close |
| 08/12/2019 | $2.31 |
| 08/13/2019 | $2.45 |
| 08/14/2019 | $2.17 |
| 08/15/2019 | $1.95 |
| 08/16/2019 | $2.09 |
| Healthcare Historical Prices |
| ACER is categorized under the Healthcare sector; below are some other companies in the same sector:
ACET Historical Stock Prices Also explore: ACER shares outstanding history |
